Page last updated: 2024-10-30

lansoprazole and Dystonia

lansoprazole has been researched along with Dystonia in 1 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Dystonia: An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sharif, A1
Carr, L1
Saliakellis, E1
Chakraborty, H1

Other Studies

1 other study available for lansoprazole and Dystonia

ArticleYear
Paroxysmal head drops with ataxia-like symptoms presenting as Sandifer syndrome in a 3-year old girl.
    BMJ case reports, 2020, Mar-04, Volume: 13, Issue:3

    Topics: Ataxia; Child, Preschool; Diagnosis, Differential; Dystonia; Female; Gastroesophageal Reflux; Humans

2020